DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Fragmin (Dalteparin Sodium) - Summary

 


Nutrilib.com
A comprihensive source of nutritional information

FRAGMIN SUMMARY

FRAGMIN Injection (dalteparin sodium injection) is a sterile, low molecular weight heparin.

FRAGMIN Injection is indicated for the prophylaxis of ischemic complications in unstable angina and non-Q-wave myocardial infarction, when concurrently administered with aspirin therapy (as described in CLINICAL TRIALS, Prophylaxis of Ischemic Complications in Unstable Angina and Non-Q-Wave Myocardial Infarction).

FRAGMIN is also indicated for the prophylaxis of deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE):

  • In patients undergoing hip replacement surgery;
  • In patients undergoing abdominal surgery who are at risk for thromboembolic complications;
  • In medical patients who are at risk for thromboembolic complications due to severely restricted mobility during acute illness.


See all Fragmin indications & dosage >>

FRAGMIN NEWS HIGHLIGHTS

Published Studies Related to Fragmin (Dalteparin)

Long-term effect of dalteparin in the prevention of neovascularization of iris in recent-onset central retinal vein occlusion. [2008.09]

Xa inhibition and coagulation activity--the influence of prolonged dalteparin treatment and gender in patients with acute coronary syndrome and healthy individuals. [2008.03]

Long-term dalteparin in pregnancy not associated with a decrease in bone mineral density: substudy of a randomized controlled trial. [2007.08]

Prolonged thromboprophylaxis with Dalteparin during immobilization after ankle fracture surgery: a randomized placebo-controlled, double-blind study. [2007.08]

The effect of dalteparin on coagulation activation during pregnancy in women with thrombophilia. A randomized trial. [2007.07]

more >>

Clinical Trials Related to Fragmin (Dalteparin)

Fragmin In The Treatment Of Acute Deep-Vein Thrombosis With Or Without Pulmonary Embolism In Cancer Patients [Enrolling by invitation]

Dalteparin's Influence on Renally Compromised: Anti-Ten-A Study (DIRECT) [Completed]

Outpatient Treatment Of Deep Venous Thrombosis (DVT) Using Subcutaneous Dalteparin (Fragmin) In Low Risk Cancer Patients [Terminated]

Fragmin in Ovarian Cancer: Utility on Survival (FOCUS) [Recruiting]

Study Of The Effect Of Fragmin In The Treatment Of Neuroischaemic Foot Ulcers In Diabetic Patients [Recruiting]

more >>

Page last updated: 2008-11-03

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008